Last updated on May 2020

A Study of OV101 in Individuals With Angelman Syndrome (AS)

Brief description of study

The purpose of this study is to assess the efficacy and safety of oral OV101 (gaboxadol) in pediatric subjects with Angelman syndrome.

Clinical Study Identifier: NCT04106557

Find a site near you

Start Over

Ovid Therapeutics Investigative Site

Heidelberg, Australia
  Connect »